{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:22:59Z","timestamp":1789438979021,"version":"build-2803163510"},"reference-count":390,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.pbb.2011.02.002","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T09:27:10Z","timestamp":1297416430000},"page":"190-210","source":"Crossref","is-referenced-by-count":66,"title":["Alzheimer's disease and age-related memory decline (preclinical)"],"prefix":"10.1016","volume":"99","author":[{"suffix":"Jr.","given":"Alvin V.","family":"Terry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2011.02.002_bb0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.schres.2008.08.004","article-title":"Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial","volume":"107","author":"Akhondzadeh","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1472-8206.2006.00411.x","article-title":"Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice","volume":"20","author":"Akhtar","year":"2006","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.pnpbp.2004.12.008","article-title":"Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging","volume":"29","author":"Araujo","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.02.002_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0197-4580(96)00162-5","article-title":"The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys","volume":"18","author":"Arnsten","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pbb.2011.02.002_bb0030","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor","volume":"302","author":"Arrang","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.02.002_bb0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0306-4522(87)90279-X","article-title":"Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors","volume":"23","author":"Arrang","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.02.002_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","article-title":"Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies","volume":"68","author":"Auld","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0045","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1073\/pnas.96.9.5280","article-title":"Age-related deficits in spatial memory are correlated with deficits in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway","volume":"96","author":"Bach","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pbb.2011.02.002_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.2001.tb03654.x","article-title":"Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer","volume":"939","author":"Bachurin","year":"2001","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"10.1016\/j.pbb.2011.02.002_bb0055","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1365-2648.2010.05279.x","article-title":"Forgetfulness and older adults: concept analysis","volume":"66","author":"Ballard","year":"2010","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.pbb.2011.02.002_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s002130051082","article-title":"The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats","volume":"146","author":"Ballard","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1474-4422(08)70295-3","article-title":"The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial","volume":"8","author":"Ballard","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0070","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1073\/pnas.95.25.15020","article-title":"Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory","volume":"95","author":"Barad","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pbb.2011.02.002_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12031-008-9139-6","article-title":"The novel cholinesterase\u2013monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats","volume":"37","author":"Bar-Am","year":"2009","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bjp.0705964","article-title":"Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist","volume":"143","author":"Barbier","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0085","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0090","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0091-3057(90)90385-U","article-title":"The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates","volume":"35","author":"Barnes","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb0095","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-3565(24)35328-5","article-title":"The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist","volume":"292","author":"Bartolomeo","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exnr.2000.7397","article-title":"On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis","volume":"163","author":"Bartus","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00001756-200403010-00025","article-title":"The role of platelet activating factor in prion and amyloid-b neurotoxicity","volume":"15","author":"Bate","year":"2004","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2011.02.002_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-6980(02)00031-X","article-title":"Prostaglandins and other lipid mediators in Alzheimer's disease","volume":"68\u20139","author":"Bazan","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.pbb.2011.02.002_bb0120","first-page":"233","article-title":"Immunotoxin lesion of the cholinergic nucleus basalis causes Abeta deposition: towards a physiologic animal model of Alzheimer's disease","volume":"3","author":"Beach","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb0125","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pbb.2011.02.002_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.me.37.020186.000321","article-title":"Clinical pharmacology of nicotine","volume":"37","author":"Benowitz","year":"1986","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pbb.2011.02.002_bb0135","first-page":"A64","article-title":"5-HT6 antisense oligonucleotide i.c.v. affects rat performance in the water maze and feeding","volume":"11","author":"Bentley","year":"1997","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0091-3057(01)00448-8","article-title":"Effects of MDL 73005 on water-maze performances and locomotor activity in scopolamine-treated rats","volume":"68","author":"Bertrand","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.02.002_bb2025","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.2174\/138161206777698855","article-title":"Improving memory: a role for phosphodiesterases","volume":"12","author":"Blokland","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00002512-200421010-00004","article-title":"Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study","volume":"21","author":"Boada-Rovira","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pbb.2011.02.002_bb0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1568007043482615","article-title":"5-HT4 receptors","volume":"3","author":"Bockaert","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Diord"},{"key":"10.1016\/j.pbb.2011.02.002_bb0165","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2004.07.040","article-title":"Inhibition of Phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance","volume":"47","author":"Boess","year":"2004","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb2020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.nurt.2008.10.042","article-title":"Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer\u2019s disease","volume":"6","author":"Bolognesi","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pbb.2011.02.002_bb0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1098-2396(200004)36:1<35::AID-SYN4>3.0.CO;2-Y","article-title":"Mapping of serotonin 5-HT4 receptor mRNA and ligand binding sites in the post-mortem human brain","volume":"36","author":"Bonaventure","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2011.02.002_bb0175","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bcp.2006.10.031","article-title":"Histamine H3 receptor antagonist: from target identification to drug leads","volume":"73","author":"Bonaventure","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0223-5234(00)01209-5","article-title":"5-HT6 receptor antagonists: lead optimization and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonmides","volume":"36","author":"Bos","year":"2001","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb0185","doi-asserted-by":"crossref","first-page":"10518","DOI":"10.1073\/pnas.1834280100","article-title":"A mouse model of Rubinstein\u2013Taybi syndrome: defective long-term memory is ameliorated by inhibitors of Phosphodiesterase 4","volume":"100","author":"Bourtchouladze","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pbb.2011.02.002_bb0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2009.10.003","article-title":"AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model","volume":"58","author":"Bradley","year":"2010","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0091-3057(94)00435-L","article-title":"AF150(S): a new functionally selective M1 agonist improves cognitive performance in rats","volume":"51","author":"Brandeis","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb0200","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00001756-199410000-00020","article-title":"Ondansetron fails to attenuate a scopolamine-induced deficit in a stone maze task","volume":"5","author":"Bratt","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2011.02.002_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0091-3057(96)00354-1","article-title":"Functional characterization of the novel neuronal nicotinic receptor ligand GTS-21 in vitro and in vivo","volume":"57","author":"Briggs","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(96)00010-6","article-title":"Nicotine cue: lack of effect of the alpha 7 nicotinic receptor antagonist methyllycaconitine","volume":"301","author":"Brioni","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbr.2003.11.001","article-title":"Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan","volume":"153","author":"Browman","year":"2004","journal-title":"Behav Brain Res"},{"issue":"5","key":"10.1016\/j.pbb.2011.02.002_bb0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/mi.4.5.8","article-title":"Neuronal nicotinic receptor subtypes: defining therapeutic targets","volume":"4","author":"Buccafusco","year":"2004","journal-title":"Mol Interv"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb0225","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1517\/14728210903257796","article-title":"Emerging cognitive enhancing drugs","volume":"14","author":"Buccafusco","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"issue":"7","key":"10.1016\/j.pbb.2011.02.002_bb0230","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bcp.2009.06.102","article-title":"A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists","volume":"78","author":"Buccafusco","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0235","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0306-4522(02)00937-5","article-title":"Potential cognitive actions of (n-propargyl-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task","volume":"119","author":"Buccafusco","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.02.002_bb0240","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bcp.2007.07.010","article-title":"Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys","volume":"74","author":"Buccafusco","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb0245","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/jpet.108.145292","article-title":"Desensitization of nicotinic acetylcholine receptors as a strategy for drug development","volume":"328","author":"Buccafusco","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-009-1701-6","article-title":"Activation of 5-HT6 receptors facilitates attentional set shifting","volume":"208","author":"Burnham","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0255","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2011.02.002_bb0260","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjp.0707178","article-title":"5-HT4 receptor agonists increase sAPP\u03b1 levels in the cortex and hippocampus of male C57BL\/6j mice","volume":"150","author":"Cachard-Chastel","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbr.2007.10.008","article-title":"Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57BL\/6j mice","volume":"187","author":"Cachard-Chastel","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0270","first-page":"19","article-title":"Characterization of the selective 5-HT6 receptor antagonist SB-271046 in behavioral models of cognition","volume":"776","author":"Callahan","year":"2004","journal-title":"Soc Neurosci Abstr"},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2011.02.002_bb0275","first-page":"S198","article-title":"Pharmacological characterization of MEM 3454, a novel nicotinic alpha7 receptor partial agonist: therapeutic potential for the cognitive deficits associated with Alzheimer's disease and schizophrenia","volume":"31","author":"Callahan","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb0280","first-page":"883","article-title":"Characterization of the 5-HT6 receptor agonist, WAY 181187 and antagonist, SB 742457: effects on recognition, associative and spatial reference memory function in young animals","author":"Callahan","year":"2009","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pbb.2011.02.002_bb0285","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0091-3057(92)90449-P","article-title":"Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset","volume":"42","author":"Carey","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(01)01440-6","article-title":"SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals","volume":"16","author":"Carey","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(97)80988-6","article-title":"Dose related impairments of spatial learning by intrahippocampal scopolamine and antagonism by ondansetron, a 5-HT3 receptor antagonist","volume":"82","author":"Carli","year":"1997","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0300","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JAD-2008-15214","article-title":"Lessons learned from failed and discontinued clinical trials for the treatment of Alzheimer's disease: future directions","volume":"15","author":"Carlsson","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pbb.2011.02.002_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(95)00241-A","article-title":"Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications","volume":"69","author":"Cassel","year":"1995","journal-title":"Neuroscience"},{"issue":"20","key":"10.1016\/j.pbb.2011.02.002_bb0310","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/anie.200700256","article-title":"A small molecule targeting the multifactorial nature of Alzheimer's disease","volume":"46","author":"Cavalli","year":"2007","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.pbb.2011.02.002_bb0315","series-title":"The state of aging and health in America","author":"Centers for Disease Control and Prevention and The Merck Company Foundation","year":"2007"},{"key":"10.1016\/j.pbb.2011.02.002_bb0320","first-page":"905","article-title":"Effect of histamine H3-receptor antagonist clobenpropit on spatial memory of radial maze performance in rats","volume":"21","author":"Chen","year":"2000","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb0325","first-page":"355","article-title":"Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147","volume":"23","author":"Chen","year":"2002","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"10.1016\/j.pbb.2011.02.002_bb0330","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jnr.22345","article-title":"DMXB (GTS-21) ameliorates the cognitive deficits in beta amyloid(25\u201335(\u2212)) injected mice through preventing the dysfunction of alpha7 nicotinic receptor","volume":"88","author":"Chen","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0335","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2174\/138161205774370762","article-title":"Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease","volume":"11","author":"Clader","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pbb.2011.02.002_bb0340","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(94)90498-7","article-title":"Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse","volume":"259","author":"Clapham","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0345","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/jm049243i","article-title":"Discovery of 5-arlsulfonamido-3(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists","volume":"48","author":"Cole","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb0350","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1523\/JNEUROSCI.2693-05.2005","article-title":"Acute \u03b3-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease","volume":"25","author":"Comery","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0355","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tips.2008.12.002","article-title":"Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0360","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00001756-199406020-00018","article-title":"5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex","volume":"5","author":"Consolo","year":"2004","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2011.02.002_bb0370","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/JAD-2007-11411","article-title":"Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology","volume":"11","author":"Coyle","year":"2007","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb0375","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12264-008-0204-5","article-title":"A novel derivative of xanomeline improved memory function in aged mice","volume":"24","author":"Cui","year":"2008","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.pbb.2011.02.002_bb0380","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/cr.2008.292","article-title":"Enhancement of memory function in aged mice by a novel derivative of xanomeline","volume":"18","author":"Cui","year":"2008","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb0390","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0091-3057(91)90045-4","article-title":"The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents","volume":"39","author":"Dawson","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bjp.0703288","article-title":"In vivo effects of the 5-HT(6)antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate","volume":"130","author":"Dawson","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0400","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0893-133X(01)00265-2","article-title":"The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus","volume":"25","author":"Dawson","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0405","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.bcp.2006.12.004","article-title":"Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test","volume":"73","author":"Day","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0410","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1021\/bi0101392","article-title":"A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation","volume":"40","author":"De Ferrari","year":"2001","journal-title":"Biochemistry"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2011.02.002_bb0415","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejphar.2010.06.064","article-title":"The subtype-selective nicotinic acetylcholine receptor positive allosteric modulator 2087101 facilitates neurotransmission in the brain","volume":"643","author":"de Filippi","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"10.1016\/j.pbb.2011.02.002_bb0420","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1021\/jm901902w","article-title":"Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives","volume":"53","author":"de Los R\u00edos","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb0425","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3565(24)37015-6","article-title":"ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys","volume":"283","author":"Decker","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0430","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pbb.2004.09.019","article-title":"Phosphodiesterase inhibition by sidenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats","volume":"79","author":"Devan","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb0435","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-005-0232-z","article-title":"Phosphodiesterase inhibition by sidenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition","volume":"183","author":"Devan","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0440","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-8993(02)03483-2","article-title":"GABA(A) receptor antagonists enhance cortical acetylcholine release induced by 5-HT(3) receptor blockade in freely moving rats","volume":"956","author":"Diez-Ariza","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0445","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2008.02.108","article-title":"The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterase 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging","volume":"1216","author":"Domek-Lopacinska","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0450","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0091-3057(91)90606-3","article-title":"The effect of ondansetron on cognitive performance in the marmoset","volume":"38","author":"Domeney","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"issue":"9634","key":"10.1016\/j.pbb.2011.02.002_bb0455","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(08)61074-0","article-title":"Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study","volume":"372","author":"Doody","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2011.02.002_bb0460","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00019442-200203000-00013","article-title":"Ondansetron in the treatment of cognitive decline in Alzheimer's dementia","volume":"10","author":"Dysken","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.pbb.2011.02.002_bb0465","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1254\/jjp.75.275","article-title":"Rolipram and its optical isomers, Phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats","volume":"75","author":"Egawa","year":"1997","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0470","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0165-6147(00)89081-1","article-title":"Central 5-HT4 receptors","volume":"16","author":"Eglen","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0475","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0024-3205(88)90318-9","article-title":"Nicotine enhances delayed matching-to-sample performance by primates","volume":"43","author":"Elrod","year":"1988","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0480","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","article-title":"The histamine H3 receptor: an attractive target for the treatment of cognitive disorders","volume":"154","author":"Esbenshade","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"13","key":"10.1016\/j.pbb.2011.02.002_bb0485","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1021\/jm100329q","article-title":"Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties","volume":"53","author":"Fern\u00e1ndez-Bachiller","year":"2010","journal-title":"J Med Chem"},{"issue":"3\u20134","key":"10.1016\/j.pbb.2011.02.002_bb0490","first-page":"221","article-title":"Progress in medicinal chemistry of novel selective muscarinic agonists","volume":"9","author":"Fisher","year":"1993","journal-title":"Drug Des Discov"},{"key":"10.1016\/j.pbb.2011.02.002_bb0495","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1046\/j.1471-4159.1998.70051991.x","article-title":"M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice","volume":"70","author":"Fisher","year":"1998","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2011.02.002_bb0500","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12031-002-0025-3","article-title":"AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease","volume":"19","author":"Fisher","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0505","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0024-3205(95)00022-X","article-title":"Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies","volume":"56","author":"Flynn","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0510","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/sj.npp.1300332","article-title":"The 5-HT6 receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats","volume":"29","author":"Foley","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0515","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuropharm.2008.06.061","article-title":"An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function","volume":"55","author":"Fone","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0520","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/BF02245812","article-title":"Ondansetron improves cognitive performance in the Morris water maze spatial navigation task","volume":"120","author":"Fontana","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0525","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0028-3908(97)00055-5","article-title":"The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation","volume":"36","author":"Fontana","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0530","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/jpet.102.047241","article-title":"Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization","volume":"305","author":"Fox","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0535","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"Fox","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0540","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in post-mortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.02.002_bb0545","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1126\/science.8389057","article-title":"Effects of cAMP simulate a late stage pf LTP in hippocampal CA1 neurons","volume":"260","author":"Frey","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.pbb.2011.02.002_bb0555","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0022-3565(24)37700-6","article-title":"Role of 5HT4 receptors in mouse passive avoidance test","volume":"286","author":"Galeotti","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0560","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuropharm.2009.03.011","article-title":"JNJ-10181457, a selective non-imidazole histamine H3 receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition","volume":"56","author":"Galici","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0565","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0006-8993(85)90188-X","article-title":"Opiate antagonist facilitation of time-dependent memory processes: dependence upon intact norepinephrine function","volume":"347","author":"Gallagher","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0570","first-page":"64","article-title":"PRX-07034, a potent and selective 5-HT6 antagonist, enhances novel object discrimination (NOD) memory and augments the effect of Aricept","volume":"9","author":"Gannon","year":"2006","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pbb.2011.02.002_bb0575","first-page":"1169","article-title":"Huperzine A reverses scopolamine- and muscimol-induced memory deficits in chick","volume":"21","author":"Gao","year":"2000","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pbb.2011.02.002_bb0580","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1586\/14737175.4.1.87","article-title":"Angiotensin and Alzheimer's disease: therapeutic prospects","volume":"4","author":"Gard","year":"2004","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb0585","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1527-3458.2004.tb00010.x","article-title":"TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective, and long-lasting cognitive effects","volume":"10","author":"Gatto","year":"2004","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pbb.2011.02.002_bb0590","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00210-002-0577-3","article-title":"DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer","volume":"365","author":"Ghelardini","year":"2002","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0595","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0166-4328(99)00063-7","article-title":"Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia","volume":"104","author":"Giovannini","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0600","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pbb.2011.02.002_bb0605","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1124\/jpet.109.155994","article-title":"Phosphodiesterase 10A inhibitor activity in preclinical models of positive, cognitive, and negative symptoms of schizophrenia","volume":"331","author":"Grauer","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0610","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1023\/B:BEBM.0000017097.75818.14","article-title":"Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons","volume":"136","author":"Grigorev","year":"2003","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb0615","first-page":"52","article-title":"Effects of chronic administration of dimebon on behavior and memory of SAMP 10 mice","volume":"72","author":"Grigorev","year":"2009","journal-title":"Eksp Klin Farmakol"},{"issue":"7243","key":"10.1016\/j.pbb.2011.02.002_bb0625","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.02.002_bb0630","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0024-3205(86)90516-3","article-title":"Actions of cimetidine and ranitidine at some cholinergic sites: implications in toxicology and anesthesia","volume":"39","author":"Gwee","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0635","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/13543784.17.2.169","article-title":"Histone deacetylase inhibitors: possible implications for neurodegenerative disorders","volume":"17","author":"Hahnen","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pbb.2011.02.002_bb0640","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0645","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0028-3908(99)00179-3","article-title":"The 5-HT1A antagonist, WAY 100635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys","volume":"39","author":"Harder","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0650","first-page":"245","article-title":"The 5-HT1A antagonist, WAY-100635, ameliorates the cognitive impairment induced by fornix transaction in the marmoset","volume":"127","author":"Harder","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0660","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-005-2261-z","article-title":"5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats","volume":"181","author":"Hatcher","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0665","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pharmthera.2007.08.006","article-title":"Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders","volume":"117","author":"Heal","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0670","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.euroneuro.2007.08.002","article-title":"Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice","volume":"18","author":"Hebb","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0675","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer's disease in the U.S. population: prevalence estimates using the 2000 census","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0680","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbr.2008.08.007","article-title":"5-HT4 receptor agonism in the five-choice serial reaction time task","volume":"195","author":"Hille","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0690","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2006.09.049","article-title":"SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models","volume":"553","author":"Hirst","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0695","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/jpet.107.133082","article-title":"Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)","volume":"325","author":"Hirst","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0700","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF02246107","article-title":"The selective 5HT3 antagonist, WAY-100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system","volume":"117","author":"Hodges","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0705","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/npp.2010.9","article-title":"Enhancement of attentional performance by selective stimulation of \u03b14\u03b22* nAChRs: underlying cholinergic mechanisms","volume":"35","author":"Howe","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0710","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1101\/lm.593407","article-title":"Low-frequency stimulation induces a pathway-specific late phase of LTP in the amygdale that is mediated by PKA and dependent on protein synthesis","volume":"14","author":"Huang","year":"2007","journal-title":"Learn Mem"},{"key":"10.1016\/j.pbb.2011.02.002_bb0715","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbr.2003.09.002","article-title":"Effect of the histamine H3-antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial arm maze in Sprague\u2013Dawley rats","volume":"151","author":"Huang","year":"2004","journal-title":"Behav Brain Res"},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2011.02.002_bb0720","first-page":"S185","article-title":"The nicotinic alpha7 receptor agonist MEM 3454 increases dopamine and acetylcholine release in rat medial prefrontal cortex and hippocampus alone and in combination with risperidone","volume":"31","author":"Huang","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0725","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.bcp.2007.03.010","article-title":"L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition","volume":"73","author":"Huang","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1016\/j.pbb.2011.02.002_bb0730","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.bmc.2010.04.063","article-title":"Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase","volume":"18","author":"Huang","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb0735","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10606820308261","article-title":"Scanning mutagenesis studies of the M1 muscarinic acetylcholine receptor","volume":"9","author":"Hulme","year":"1990","journal-title":"Recept Channels"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb0740","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jep.2008.05.041","article-title":"Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii","volume":"119","author":"Hung","year":"2008","journal-title":"J Ethnopharmacol"},{"issue":"17","key":"10.1016\/j.pbb.2011.02.002_bb0745","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1523\/JNEUROSCI.5269-04.2005","article-title":"A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization","volume":"25","author":"Hurst","year":"2005","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb0750","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00001756-199502000-00019","article-title":"Maze learning in aged rats is enhanced by phenserine, a novel anticholinesterase","volume":"6","author":"Ikari","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2011.02.002_bb0755","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0014-2999(96)00969-7","article-title":"Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents","volume":"321","author":"Imanishi","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.pbb.2011.02.002_bb2015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00023210-200115050-00004","article-title":"Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"15","author":"Imbimbo","year":"2001","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.pbb.2011.02.002_bb0760","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1533317506292499","article-title":"Becoming forgetful: how elderly people deal with forgetfulness in everyday life","volume":"21","author":"Imhof","year":"2006","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.pbb.2011.02.002_bb0765","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0896-6273(00)80120-8","article-title":"Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus","volume":"16","author":"Impey","year":"1996","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.pbb.2011.02.002_bb0770","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.lfs.2004.06.028","article-title":"The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats","volume":"21; 76","author":"Janas","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0775","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0166-2236(99)01471-X","article-title":"Nicotinic receptors in the brain: correlating physiology with function","volume":"22","author":"Jones","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0780","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1523\/JNEUROSCI.1850-08.2008","article-title":"Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats","volume":"28","author":"Jones","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0785","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrn731","article-title":"Emerging structure of the nicotinic acetylcholine receptors","volume":"3","author":"Karlin","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0790","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0166-4328(00)00211-4","article-title":"The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21)","volume":"113","author":"Kem","year":"2000","journal-title":"Behav Brain Res"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2011.02.002_bb0795","first-page":"413","article-title":"E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat","volume":"213","author":"Kendall","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0800","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1126\/science.304.5667.17","article-title":"Just treat, or enhance?","volume":"304","author":"Kennedy","year":"2004","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb0805","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1248\/bpb.33.702","article-title":"Piperidine-4-methanthiol ester derivatives for a selective acetylcholinesterase assay","volume":"33","author":"Kikuchi","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pbb.2011.02.002_bb0810","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2004.03.012","article-title":"5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation\u2014an effect sensitive to NMDA receptor antagonism","volume":"47","author":"King","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0815","first-page":"A12","article-title":"The selective 5-HT6 receptor antagonist Ro 04-6790 reverses age-related and chronic intermittent PCP-induced cognitive dysfunction in rats","volume":"19","author":"King","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0820","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2008.07.001","article-title":"A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory","volume":"29","author":"King","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0825","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-008-1334-1","article-title":"Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht6 receptor antagonist, Ro 04-6790, in the novel object discrimination task","volume":"202","author":"King","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0830","series-title":"An aging world. U.S. Census Bureau, International Population Reports, P95\/09-1","author":"Kinsella","year":"2009"},{"key":"10.1016\/j.pbb.2011.02.002_bb0840","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1471-4159.1996.66010047.x","article-title":"Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor","volume":"66","author":"Kohen","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2011.02.002_bb0845","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbr.2004.11.008","article-title":"Effects of histamine H3 receptor antagonists in two models of spatial learning","volume":"159","author":"Komater","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0850","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cercor\/12.2.150","article-title":"Modulation by serotonin 5-HT(4) receptors of long-term potentiation and depotentiation in the dentate gyrus of freely moving rats","volume":"12","author":"Kulla","year":"2002","journal-title":"Cereb Cortex"},{"issue":"9","key":"10.1016\/j.pbb.2011.02.002_bb0855","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1016\/j.bmc.2008.03.019","article-title":"Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models","volume":"16","author":"Kumar","year":"2008","journal-title":"Bioorg Med Chem"},{"issue":"1\u20133","key":"10.1016\/j.pbb.2011.02.002_bb0860","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2009.06.062","article-title":"Loganin improves learning and memory impairments induced by scopolamine in mice","volume":"619","author":"Kwon","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0865","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/S0024-3205(01)01056-6","article-title":"Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788","volume":"68","author":"Lachowicz","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0870","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/syn.10288","article-title":"5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex","volume":"51","author":"Lacroix","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2011.02.002_bb0875","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0028-3908(01)00123-X","article-title":"Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors","volume":"41","author":"Lamirault","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb2010","unstructured":"Langmead CJ, Austin NE, Branch CL, Brown JT, Buchanan KA, Davies CH, et al. Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1."},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb0880","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.phrs.2008.02.004","article-title":"Cognition enhancers between treating and doping the mind","volume":"57","author":"Lanni","year":"2008","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.pbb.2011.02.002_bb0890","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12272-009-1505-6","article-title":"Cognitive-enhancing activity of loganin isolated from Cornus officinalis in scopolamine-induced amnesic mice","volume":"32","author":"Lee","year":"2009","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0895","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pharmthera.2009.03.009","article-title":"A cog in cognition: how the \u03b17 nicotinic acetylcholine receptor is geared towards improving cognitive deficits","volume":"122","author":"Leiser","year":"2009","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.pbb.2011.02.002_bb0900","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/A:1017972709652","article-title":"Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels","volume":"132","author":"Lermontova","year":"2001","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.pbb.2011.02.002_bb0905","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrd1631","article-title":"The histamine H3 receptor: from gene cloning to H3 receptor drugs","volume":"4","author":"Leurs","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pbb.2011.02.002_bb0910","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00213-008-1283-8","article-title":"Increased particulate Phosphodiesterase 4 in the prefrontal cortex supports 5-HT4 receptor-induced improvement of object recognition memory in the rat","volume":"202","author":"Levallet","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0915","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","article-title":"Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies","volume":"11","author":"Levey","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb0920","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/neu.10151","article-title":"Nicotinic receptor subtypes and cognitive function","volume":"53","author":"Levin","year":"2002","journal-title":"J Neurobiol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0925","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bcp.2007.07.019","article-title":"Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function","volume":"74","author":"Levin","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0930","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.expneurol.2007.02.001","article-title":"5-HT4 receptor and Alzheimer's disease: the amyloid connection","volume":"205","author":"Lezoualc'h","year":"2007","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb0935","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S1461145705006425","article-title":"Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity","author":"Li","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0940","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2006.11.060","article-title":"5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus","volume":"1134","author":"Li","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb0945","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.pbb.2011.02.002_bb0950","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-3565(24)37840-1","article-title":"Neurochemical and behavioral effects of ciproxifan, a potent histamine H3 receptor antagonist","volume":"287","author":"Ligneau","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0955","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.106.111039","article-title":"BF2.649 [1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: preclinical pharmacology","volume":"320","author":"Ligneau","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0960","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00213-007-0934-5","article-title":"Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex","volume":"196","author":"Loiseau","year":"2008","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb0965","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuropharm.2007.04.007","article-title":"Partial agonist and neuromodulatory activity of S 24795 for alpha7 nAChR responses of hippocampal interneurons","volume":"53","author":"Lopez-Hernandez","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0970","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2174\/156652309789753392","article-title":"Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?","volume":"9","author":"Lowenstein","year":"2008","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb0975","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1152\/jn.2002.88.3.1270","article-title":"Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus","volume":"88","author":"Lu","year":"2002","journal-title":"J Neurophysiol"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb0980","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000272424","article-title":"Incidence of mild cognitive impairment: a systematic review","volume":"29","author":"Luck","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb0985","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.expneurol.2007.04.007","article-title":"Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil","volume":"206","author":"Luques","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2011.02.002_bb0990","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuropharm.2005.01.007","article-title":"Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat","volume":"48","author":"Luttgen","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2010.12.024","article-title":"The likelihood of cognitive enhancement","author":"Lynch","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb1000","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2174\/156720510791383831","article-title":"Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease","volume":"7","author":"Maher-Edwards","year":"2010","journal-title":"Curr Alzheimer Res"},{"issue":"15","key":"10.1016\/j.pbb.2011.02.002_bb1005","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1016\/j.bmc.2008.06.053","article-title":"Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models","volume":"16","author":"Malviya","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1010","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.bmc.2009.06.032","article-title":"Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models","volume":"17","author":"Malviya","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1015","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuropharm.2004.06.033","article-title":"Modulation of memory processes and cellular excitability in the dentate gyrus of freely moving rats by a 5-HT4 receptor partial agonist, and an antagonist","volume":"47","author":"Marchetti","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1020","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1460-9568.2006.05003.x","article-title":"Lack of localization of 5-Ht6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release","volume":"24","author":"Marcos","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb1025","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjp.2008.281","article-title":"Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat","volume":"155","author":"Marcos","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0006-8993(90)91240-H","article-title":"Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates","volume":"526","author":"Martinez-Mir","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1471-4159.2001.00448.x","article-title":"Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol","volume":"78","author":"Maruyama","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1040","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.3992249","article-title":"Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation","volume":"228","author":"Mash","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.pbb.2011.02.002_bb1045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)38802-0","article-title":"Evidence for involvement of central 5-HT4 receptors in cholinergic function associated with cognitive processes: behavioral electrophysiological, and neurochemical studies","volume":"296","author":"Matsumoto","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1050","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1016\/j.bmcl.2005.06.067","article-title":"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists","volume":"15","author":"Mattsson","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pbb.2011.02.002_bb1055","first-page":"740","article-title":"Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials","volume":"11","author":"McArthur","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pbb.2011.02.002_bb1060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.ph.57.030195.002513","article-title":"Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons","volume":"57","author":"McGehee","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1065","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/jpet.107.120311","article-title":"GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models","volume":"321","author":"Medhurst","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1070","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bcp.2007.01.007","article-title":"Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats","volume":"73","author":"Medhurst","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0091-3057(95)00248-U","article-title":"Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice","volume":"50","author":"Meguro","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb1080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0149-7634(99)00067-6","article-title":"5-HT system and cognition","volume":"23","author":"Meneses","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2011.02.002_bb1085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1358\/dnp.2001.14.7.660941","article-title":"Role of 5-Ht6 receptors in memory formation","volume":"4","author":"Meneses","year":"2001","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.pbb.2011.02.002_bb1090","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.neubiorev.2007.02.001","article-title":"5-HT(1A) receptors and memory","volume":"31","author":"Meneses","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2011.02.002_bb1095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbr.2007.11.023","article-title":"The effects of the 5-HT6 receptor agonist EMD and the 5-HT7 receptor agonist AS19 on memory formation","volume":"195","author":"Meneses","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1124\/jpet.104.069625","article-title":"The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis","volume":"311","author":"Millan","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"5971","key":"10.1016\/j.pbb.2011.02.002_bb1105","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.327.5971.1309","article-title":"Pharmacology. The puzzling rise and fall of a dark-horse Alzheimer's drug","volume":"327","author":"Miller","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pbb.2011.02.002_bb1110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/gps.826","article-title":"The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure","volume":"18","author":"Mintzer","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pbb.2011.02.002_bb1115","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.npp.1300024","article-title":"Selective 5-HT1A antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat","volume":"28","author":"Misane","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuropharm.2005.10.002","article-title":"BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism","volume":"50","author":"Mitchell","year":"2006","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb1130","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0022-3565(25)13075-9","article-title":"Effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1-H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, on impaired learning and memory in animal models","volume":"277","author":"Miyamoto","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb2005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2011.02.002_bb1135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0024-3205(97)00406-2","article-title":"Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice","volume":"61","author":"Miyazaki","year":"1997","journal-title":"Life Sci"},{"issue":"12","key":"10.1016\/j.pbb.2011.02.002_bb1140","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1016\/j.bmcl.2010.04.108","article-title":"Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors","volume":"20","author":"Mohamed","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pbb.2011.02.002_bb1145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.neuropharm.2007.06.016","article-title":"VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux","volume":"53","author":"Mohler","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)13616-X","article-title":"Cloning and expression of a novel serotonin receptor with high-affinity for tricyclic psychotropic-drugs","volume":"43","author":"Monsma","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.npp.1300813","article-title":"Subchronic rolipram delivery activates hippocampal CREB and Arc, enhances retention and slows down extinction of conditioned fear","volume":"31","author":"Monti","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1160","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1124\/jpet.102.034249","article-title":"SL65.0155, a novel 5-hydroxytryptamine4 receptor partial agonist with potent cognition-enhancing properties","volume":"302","author":"Moser","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13607860220126808","article-title":"Nicotine's effect on neural and cognitive functioning in an aging population","volume":"6","author":"Murray","year":"2002","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.pbb.2011.02.002_bb1170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbr.2004.06.024","article-title":"The effect of intrahippocampal injections of ritanserin (5-HT2A\/2C antagonist) and granisetron (5-HT3 antagonist) on learning as assessed in the spatial version of the water maze","volume":"157","author":"Naghdi","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1175","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1523\/JNEUROSCI.1796-04.2004","article-title":"The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging","volume":"24","author":"Navakkode","year":"2004","journal-title":"J Neurosci"},{"issue":"19","key":"10.1016\/j.pbb.2011.02.002_bb1180","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1073\/pnas.0701321104","article-title":"Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators","volume":"104","author":"Ng","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb1185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbr.2008.02.023","article-title":"The role of 5-HT1A receptors in learning and memory","volume":"195","author":"Ogren","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0361-9230(96)00349-8","article-title":"Ameliorating effects of SDZ ENA 713 on age-associated decreases in learning performance and brain choline acetyltransferase activity in rats","volume":"43","author":"Ohara","year":"1997","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb1195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/11038120701441080","article-title":"Awareness through interaction in everyday occupations: experiences of people with Alzheimer's disease","volume":"15","author":"Ohman","year":"2008","journal-title":"Scand J Occup Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(01)01500-X","article-title":"Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys","volume":"433","author":"Ou","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-008-1171-2","article-title":"H3 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval","volume":"202","author":"Pascoli","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2125.2008.03348.x","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects","volume":"67","author":"Patat","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb1220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00001756-199801050-00035","article-title":"Phenserine, a novel acetylcholinesterase inhibitor, attenuates impaired learning of rats in a 14-unit T-maze induced by blockade of the N-methyl-d-aspartate receptor","volume":"9","author":"Patel","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2011.02.002_bb1225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000080104","article-title":"Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy","volume":"72","author":"Patil","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1230","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuroscience.2007.09.022","article-title":"Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695","volume":"150","author":"Peng","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.02.002_bb1235","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.pbb.2005.05.005","article-title":"Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task","volume":"81","author":"Perez-Garcia","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb1240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.pbb.2011.02.002_bb1245","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1523\/JNEUROSCI.22-16-07272.2002","article-title":"Ciproxifan, a histamine H3-receptor antagonist\/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat","volume":"22","author":"Pillot","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb1250","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.201000210","article-title":"Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors","author":"Pisani","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(96)00586-9","article-title":"Itasetron (DAU 6215) prevents age-related memory deficits in the rat in a multiple choice avoidance task","volume":"311","author":"Pitsikas","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1260","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-3057(96)00516-3","article-title":"Different effects of tropisetron and ondansetron in learning and memory paradigms","volume":"56","author":"Pitsikas","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb1265","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0197-4580(93)90039-E","article-title":"DAU 6215, a novel 5-HT3 receptor antagonist, improves performance in the aged rat in the Morris water maze task","volume":"14","author":"Pitsikas","year":"1993","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pbb.2011.02.002_bb1270","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(03)03091-9","article-title":"The 5-HT1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task","volume":"983","author":"Pitsikas","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1275","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0306-4522(93)90191-H","article-title":"A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas","volume":"52","author":"Pollard","year":"1993","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb1280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s002130050538","article-title":"Central nicotinic receptor agonists ABT-418, ABT-089, and (\u2212)-nicotine reduce distractibility in adult monkeys","volume":"136","author":"Prendergast","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb1285","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s002130050538","article-title":"Central nicotinic receptor agonists ABT-418, ABT-089, and (\u2212)-nicotine reduce distractibility in adult monkeys","volume":"136","author":"Prendergast","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.02.002_bb1290","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-2999(97)01301-0","article-title":"Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast","volume":"337","author":"Prickaerts","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1295","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0306-4522(02)00199-9","article-title":"Effects of two selective Phosphodiesterase type 5 inhibitors, sidenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat","volume":"113","author":"Prickaerts","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.02.002_bb1300","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-004-1967-7","article-title":"Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation","volume":"177","author":"Prickaerts","year":"2005","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb1305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb1310","first-page":"226","article-title":"Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release","volume":"18","author":"Quirion","year":"1993","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb1315","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1523\/JNEUROSCI.15-02-01455.1995","article-title":"Facilitation of acetylcholine release and cognitive performance by an M2-muscarinic receptor antagonist in aged memory-impaired rats","volume":"15","author":"Quirion","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb1320","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cbi.2005.10.099","article-title":"Role of acetylcholinesterase inhibitors in the regulation of amyloid beta precursor protein (AbetaPP) metabolism","volume":"157\u20138","author":"Racchi","year":"2005","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.pbb.2011.02.002_bb1325","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0006-8993(95)01471-3","article-title":"Involvement of GABA systems in acetylcholine release induced by 5-HT3 receptor blockade in slices from rat entorhinal cortex","volume":"712","author":"Ramirez","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1330","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0896-6273(03)00694-9","article-title":"Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline","volume":"40","author":"Ramos","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2011.02.002_bb1335","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-3057(82)90344-6","article-title":"Brain cyclic AMP and memory in mice","volume":"17","author":"Randt","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"10.1016\/j.pbb.2011.02.002_bb1340","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1212\/WNL.54.12.2261","article-title":"Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group","volume":"54","author":"Raskind","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1350","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-008-1273-x","article-title":"Selective Phosphodiesterase inhibitors: a promising target for cognition enhancement","volume":"202","author":"Reneerkens","year":"2009","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb1355","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pnpbp.2008.11.018","article-title":"Effect of R3487\/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats","volume":"33","author":"Rezvani","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.02.002_bb1360","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/jm021085c","article-title":"Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent, selective 5-HT6 receptor antagonist","volume":"46","author":"Riemer","year":"2003","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.pbb.2011.02.002_bb1365","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bmc.2010.01.071","article-title":"Targeting Alzheimer's disease: novel indanone hybrids bearing a pharmacophoric fragment of AP2238","volume":"18","author":"Rizzo","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1370","doi-asserted-by":"crossref","first-page":"44881","DOI":"10.1074\/jbc.M109008200","article-title":"The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein","volume":"276","author":"Robert","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-8993(02)02360-0","article-title":"The distribution of 5-HT6 receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT6 receptor antagonist I-125 SB-258585","volume":"934","author":"Roberts","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1380","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1460-9568.2005.03937.x","article-title":"PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats","volume":"21","author":"Rodefer","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb1385","first-page":"746","article-title":"Attentional set-shifting in rats and monkeys: effects of cholinergic challenges","author":"Rodefer","year":"2007","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pbb.2011.02.002_bb1390","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/sj.npp.1301654","article-title":"Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics","volume":"33","author":"Rodefer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1395","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002130100840","article-title":"5-HT6 receptor antagonists enhance retention of a water-maze task in the rat","volume":"158","author":"Rogers","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1400","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bcp.2009.05.033","article-title":"Preclinical pharmacology of the \u03b14\u03b22 nAChR partial agonist varenicline related to effects on reward, mood and cognition","volume":"78","author":"Rollema","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1405","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.bjp.0706827","article-title":"Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways","volume":"148","author":"Romero","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb1410","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.108.150094","article-title":"Pro-cognitive and neuroprotective activity of a novel \u03b17 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders","volume":"329","author":"Roncarati","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1415","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.2174\/138161205774370799","article-title":"Phosphodiesterase inhibitors for cognitive enhancement","volume":"11","author":"Rose","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pbb.2011.02.002_bb1420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-003-1683-8","article-title":"Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders","volume":"174","author":"Roth","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1425","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/sj.bjp.0703457","article-title":"Characterization of SB-271046: a potent, selective and orally active 5-HT6 receptor antagonist","volume":"130","author":"Routledge","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0166-4328(03)00116-5","article-title":"Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats","volume":"145","author":"Rowe","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1435","doi-asserted-by":"crossref","first-page":"S647","DOI":"10.1016\/j.jalz.2006.05.2180","article-title":"Histamine H3 receptor antagonists elicit pro-cognitive effects on episodic and spatial reference memories in young and aged animals","volume":"2","author":"Rowe","year":"2006","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pbb.2011.02.002_bb1440","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1523\/JNEUROSCI.4163-06.2007","article-title":"Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats","volume":"27","author":"Rowe","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.02.002_bb1445","first-page":"9","article-title":"Serotonin 5-HT6 receptor antagonists modulate episodic, spatial and working memory highlighting a potential therapeutic role in alleviating deficits associated with mild cognitive impairment and Alzheimer's disease","volume":"685","author":"Rowe","year":"2008","journal-title":"Soc Neurosci Abstr"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb1450","first-page":"883","article-title":"Characterization of the 5-HT6 receptor agonist, WAY 181187 and antagonist, SB 742457: effects on spatial reference and spatial working memory function in aged F344 rats","author":"Rowe","year":"2009","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pbb.2011.02.002_bb1455","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/bbrc.1993.1619","article-title":"A novel rat serotonin (5-HT6) receptor-molecular cloning, localization and stimulation of cAMP accumulation","volume":"193","author":"Ruat","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb1460","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0022-510X(92)90296-W","article-title":"Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates","volume":"107","author":"Rupniak","year":"1992","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb1465","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0091-3057(99)00037-4","article-title":"Facilitation of memory performance by a novel muscarinic agonist in young and old rats","volume":"63","author":"Ruske","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb1470","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2005.04.021","article-title":"The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampus","volume":"164","author":"Rutten","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1475","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.nlm.2005.09.002","article-title":"Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action","volume":"85","author":"Rutten","year":"2006","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1480","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2006.11.041","article-title":"Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors","volume":"558","author":"Rutten","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1485","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00213-007-0999-1","article-title":"Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques","volume":"196","author":"Rutten","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1490","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjopharm.2009.06.003","article-title":"Drug development for Alzheimer's disease: where are we now and where are we headed?","volume":"7","author":"Sabbagh","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.pbb.2011.02.002_bb1495","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.ejmech.2009.07.026","article-title":"Synthesis and pharmacological evaluation of novel N-alkyl\/aryl substituted thiazolidinone arecoline analogues as muscarinic M1 receptor agonists in Alzheimer's dementia models","volume":"44","author":"Sadashiva","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1500","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1471-4159.2003.01801.x","article-title":"Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase\u2013monoamine oxidase inhibitor","volume":"86","author":"Sagi","year":"2003","journal-title":"J Neurochem"},{"issue":"16","key":"10.1016\/j.pbb.2011.02.002_bb1505","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1016\/j.bmc.2010.06.095","volume":"18","author":"Samadi","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1510","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.bcp.2009.06.021","article-title":"Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities","volume":"78","author":"Schaffhauser","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1515","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1124\/jpet.105.086363","article-title":"Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties","volume":"314","author":"Schechter","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1520","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","article-title":"Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466","volume":"33","author":"Schechter","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb1525","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/jpet.103.051912","article-title":"The subtype selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and working memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated monkeys","volume":"306","author":"Scheider","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1530","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1472-8206.1994.tb00789.x","article-title":"Modulation of neurotransmitter release via histamine H3 heteroreceptors","volume":"8","author":"Schlicker","year":"1994","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1535","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","article-title":"Preclinical characterization of selective phosphodiesterase 10A inhibitiors: a new therapeutic approach to the treatment of schizophrenia","volume":"325","author":"Schmidt","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb1540","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3565(24)34957-2","article-title":"Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys","volume":"290","author":"Schneider","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1545","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.euroneuro.2006.06.009","article-title":"Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating","volume":"17","author":"Schreiber","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1550","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1345\/aph.1E487","article-title":"Phosphodiesterase 5 inhibitors for erectile dysfunction","volume":"39","author":"Setter","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pbb.2011.02.002_bb1555","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-008-1250-4","article-title":"Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys","volume":"202","author":"Seu","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.02.002_bb1560","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1556\/APhysiol.93.2006.1.6","article-title":"Effect of sidenafil (Viagra) on memory retention of a passive avoidance response in rats","volume":"93","author":"Shafiei","year":"2006","journal-title":"Acta Physiol Hung"},{"key":"10.1016\/j.pbb.2011.02.002_bb1565","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejmech.2008.03.003","article-title":"Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives","volume":"44","author":"Sheng","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1570","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb1575","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.neuropharm.2006.10.005","article-title":"Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats","volume":"52","author":"Shoham","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1580","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neulet.2010.02.031","article-title":"A novel derivative of xanomeline improves fear cognition in aged mice","volume":"473","author":"Si","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.02.002_bb1585","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.ejca.2008.09.009","article-title":"Lost in translation: problems and pitfalls in translating laboratory observations to clinical utility","volume":"44","author":"Simon","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pbb.2011.02.002_bb1590","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1101\/lm.5.3.231","article-title":"The specific role of cGMP in hippocampal LTP","volume":"5","author":"Son","year":"1998","journal-title":"Learn Mem"},{"issue":"5","key":"10.1016\/j.pbb.2011.02.002_bb1595","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuropharm.2007.06.028","article-title":"The effects of JWB1-84-1 on memory related task performance by amyloid Abeta transgenic mice and by young and aged monkeys","volume":"53","author":"Sood","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1600","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00213-008-1310-9","article-title":"Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040","volume":"201","author":"Southam","year":"2009","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pbb.2011.02.002_bb1605","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1124\/mol.106.024901","article-title":"Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine: evidence for three distinct modes of receptor activation","volume":"70","author":"Spalding","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1610","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2004.06.070","article-title":"Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease","volume":"129","author":"Spencer","year":"2004","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.pbb.2011.02.002_bb1615","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0149-2918(04)90064-1","article-title":"Pharmacotherapeutic approaches to the treatment of Alzheimer's disease","volume":"26","author":"Standridge","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1620","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0091-3057(01)00742-0","article-title":"Pharmacological profile of SB-357134: a potent, selective brain penetrant, and orally active 5-HT(6) receptor antagonist","volume":"71","author":"Stean","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.02.002_bb1625","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1021\/jm020120c","article-title":"Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease","volume":"45","author":"Sterling","year":"2002","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb1630","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.pnpbp.2004.12.014","article-title":"The canine model of human cognitive aging and dementia: pharmacological validity of the model for assessment of human cognitive-enhancing drugs","volume":"29","author":"Studzinski","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb1635","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)37014-4","article-title":"ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties","volume":"283","author":"Sullivan","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1640","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1523\/JNEUROSCI.3110-06.2007","article-title":"Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation","volume":"27","author":"Svenningsson","year":"2007","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.pbb.2011.02.002_bb1645","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.07.005","article-title":"Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes","volume":"78","author":"Sydserff","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"10.1016\/j.pbb.2011.02.002_bb1650","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd2927","article-title":"Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system","volume":"8","author":"Taly","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2011.02.002_bb1655","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0031-6865(99)00027-8","article-title":"CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology","volume":"74","author":"Tecle","year":"2000","journal-title":"Pharm Acta Helv"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb1660","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1665","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001756-199612200-00011","article-title":"The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys","volume":"8","author":"Terry","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2011.02.002_bb1670","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002130050529","article-title":"Enhanced delayed matching performance in younger and older macaques administered the 5HT4 receptor agonist, RS 17017","volume":"135","author":"Terry","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1675","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1098-2299(199906)47:2<97::AID-DDR5>3.0.CO;2-I","article-title":"Ranitidine analog, JWS USC 75IX, enhances memory related task performance in rats","volume":"47","author":"Terry","year":"1999","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1680","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1527-3458.2005.tb00045.x","article-title":"Cotinine. A neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition","volume":"11","author":"Terry","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pbb.2011.02.002_bb1685","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00213-004-2114-1","article-title":"Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys","volume":"179","author":"Terry","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1690","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2007.12.006","article-title":"Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets","volume":"195","author":"Terry","year":"2008","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb1695","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/jpet.110.175422","article-title":"Prototypical ranitidine analog, JWS-USC-75-IX, improves information processing and cognitive function in animal models","volume":"336","author":"Terry","year":"2011","journal-title":"J. Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1700","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jama.289.11.1371","article-title":"Public health and aging: trends in aging \u2014 United States and worldwide","volume":"289","author":"The Centers for Disease Control and Prevention","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pbb.2011.02.002_bb1705","first-page":"367","article-title":"Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias","volume":"4","author":"Thomas","year":"2009","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.pbb.2011.02.002_bb1710","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.107.120436","article-title":"An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo","volume":"323","author":"Timmermann","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb1715","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.phrs.2007.07.006","article-title":"Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study","volume":"56","author":"Trabace","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1720","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrd1061","article-title":"Targeting the CREB pathway for memory enhancers","volume":"2","author":"Tully","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pbb.2011.02.002_bb1725","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.mp.4001270","article-title":"Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2\/M4 muscarinic receptor knockout mice","volume":"8","author":"Tzavara","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2011.02.002_bb1730","series-title":"World population ageing","author":"United Nations","year":"2007"},{"key":"10.1016\/j.pbb.2011.02.002_bb1735","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nurt.2008.05.008","article-title":"5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease","volume":"5","author":"Upton","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pbb.2011.02.002_bb1740","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1021\/jm00095a008","article-title":"Synthesis and cholinergic properties of N-aryl-2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethylamino analogs of ranitidine","volume":"35","author":"Valli","year":"1992","journal-title":"J Med Chem"},{"key":"10.1016\/j.pbb.2011.02.002_bb1745","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/156720507783018226","article-title":"Novel multifunctional anti-Alzheimer drugs with various CNS neurotransmitter targets and neuroprotective moieties","volume":"4","author":"Van der Schyf","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1750","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuropharm.2008.07.005","article-title":"The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents","volume":"55","author":"van der Staay","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1755","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2008.10.027","article-title":"Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion","volume":"600","author":"van Donkelaar","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1760","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-003-1668-7","article-title":"AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors","volume":"172","author":"van Kampen","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1765","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/NDT.S4048","article-title":"Update on the use of memantine in Alzheimer's disease","volume":"5","author":"van Marum","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.pbb.2011.02.002_bb1770","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cne.20447","article-title":"Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions","volume":"484","author":"Vilaro","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2011.02.002_bb1775","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1073\/pnas.172504199","article-title":"Amyloid beta-peptide inhibition of the PKA\/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling","volume":"99","author":"Vitolo","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pbb.2011.02.002_bb1780","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/jpet.110.171892","article-title":"RG3487, a novel nicotinic \u03b17 receptor partial agonist, improves cognition and sensorimotor gating in rodents","volume":"336","author":"Wallace","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1785","first-page":"SMA-45","article-title":"Pro-cognitive properties of MEM 64368, a novel nicotinic alpha 7 receptor partial agonist, following acute and chronic administration","volume":"74","author":"Wallace-Boone","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.pbb.2011.02.002_bb1790","first-page":"887","article-title":"R3487\/MEM3454, a novel nicotinic alpha 7 receptor partial agonist, improves attention and working memory performance in cynomolgus macaques","author":"Wallace-Boone","year":"2009","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pbb.2011.02.002_bb1795","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(98)00199-X","article-title":"Reversal of scopolamine-induced deficits in radial maze performance by (\u2212)-huperzine A: comparison with E2020 and tacrine","volume":"349","author":"Wang","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb1800","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.pbb.2006.03.027","article-title":"Effects of huperzine A on memory deficits and neurotrophic factors production after transient cerebral ischemia and reperfusion in mice","volume":"83","author":"Wang","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.pbb.2011.02.002_bb1805","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jnr.22237","article-title":"Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion","volume":"88","author":"Wang","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1815","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1096\/fj.04-1916fje","article-title":"Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members","volume":"18","author":"Weinreb","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.pbb.2011.02.002_bb1820","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.2741\/3069","article-title":"The neuroprotective mechanism of action of the multimodal drug ladostigil","volume":"13","author":"Weinreb","year":"2008","journal-title":"Front Biosci"},{"issue":"60","key":"10.1016\/j.pbb.2011.02.002_bb1825","first-page":"157","article-title":"TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease","author":"Weinstock","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2011.02.002_bb1830","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.2001.tb03622.x","article-title":"Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs","volume":"939","author":"Weinstock","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb1835","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00213-001-0978-x","article-title":"Effect of TV3326, a novel monoamineoxidase cholinesterase inhibitor, in rat models of anxiety and depression","volume":"160","author":"Weinstock","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.02.002_bb1840","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0278-5846(03)00053-8","article-title":"A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease","volume":"27","author":"Weinstock","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.02.002_bb1845","article-title":"Ladostigil prevents age-related glial activation and spatial memory deficits in rats","author":"Weinstock","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pbb.2011.02.002_bb1850","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000048651","article-title":"Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system","volume":"13","author":"Wesnes","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.pbb.2011.02.002_bb1855","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuropharm.2007.01.007","article-title":"Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression","volume":"52","author":"Wesolowska","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1860","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors mutant mice provide new insights drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pbb.2011.02.002_bb1865","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.neuroscience.2009.07.061","article-title":"Activation of the 5-HT6 receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus","volume":"164","author":"West","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.02.002_bb1880","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1523\/JNEUROSCI.22-07-02843.2002","article-title":"The physiological role of 5-HT2A receptors in working memory","volume":"22","author":"Williams","year":"2002","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pbb.2011.02.002_bb1885","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1212\/WNL.57.3.489","article-title":"A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD","volume":"57","author":"Winblad","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1890","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00213-003-1398-x","article-title":"Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats","volume":"167","author":"Winstanley","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.05.001","article-title":"Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system","volume":"103","author":"Witkin","year":"2004","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb1900","first-page":"586","article-title":"5-Ht6 receptor antagonists enhance memory in radial maze and object recognition tasks","author":"Wolff","year":"2002","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pbb.2011.02.002_bb1905","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00056-9","article-title":"A role for 5-Ht(6) receptors in retention of spatial learning in the Morris water maze","volume":"41","author":"Woolley","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1910","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007043482561","article-title":"5-ht6 receptors","volume":"3","author":"Woolley","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pbb.2011.02.002_bb1915","series-title":"The world is fast aging \u2014 have we noticed?","year":"2008"},{"key":"10.1016\/j.pbb.2011.02.002_bb1920","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-3-15","article-title":"Evaluation of Dimebon in cellular model of Huntington's disease","volume":"3","author":"Wu","year":"2008","journal-title":"Mol Neurodegener"},{"issue":"2","key":"10.1016\/j.pbb.2011.02.002_bb1925","first-page":"98","article-title":"Effects of TAK-147, a novel acetylcholinesterase inhibitor, on spatial memory deficit as evaluated by Morris water maze of rats","volume":"31","author":"Xu","year":"2002","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb1930","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(02)00830-3","article-title":"Effect of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitive impairment induced by chronic cerebral hypoperfusion in rats","volume":"331","author":"Xu","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.02.002_bb1935","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0022-3565(24)38024-3","article-title":"Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment","volume":"288","author":"Ye","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.02.002_bb1940","first-page":"65","article-title":"Huperzine A ameliorates the impaired memory of aged rat in the Morris water maze performance","volume":"21","author":"Ye","year":"2000","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pbb.2011.02.002_bb1945","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archpsyc.1979.01780020110012","article-title":"Vasodilators in senile dementias: a review of the literature","volume":"36","author":"Yesavage","year":"1979","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2011.02.002_bb1950","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1096\/fj.02-0198fje","article-title":"The involvement of mitogen-activated protein (MAP) kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline","volume":"16","author":"Yogev-Falach","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.pbb.2011.02.002_bb1955","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1096\/fj.05-4910fje","article-title":"A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing","volume":"20","author":"Yogev-Falach","year":"2006","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.pbb.2011.02.002_bb1960","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tips.2004.11.007","article-title":"Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders","volume":"26","author":"Youdim","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2011.02.002_bb1965","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002130000414","article-title":"Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze test in rats","volume":"150","author":"Zhang","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1970","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0893-133X(00)00108-1","article-title":"Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism","volume":"23","author":"Zhang","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1975","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.npp.1300440","article-title":"Inhibition of the phosphodiesterase (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus","volume":"29","author":"Zhang","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1980","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00213-004-2085-2","article-title":"Effects of the novel PDE4 inhibitors MEM1018 and MEM 1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.02.002_bb1985","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2005.03.018","article-title":"Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug\u2013drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs","volume":"1045","author":"Zhang","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1990","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2006.07.010","article-title":"Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study","volume":"88","author":"Zhang","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2011.02.002_bb1995","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jpba.2007.02.024","article-title":"Development of a liquid chromatography\/tandem mass spectrometry method for the quantitation of acetylcholine and related neurotransmitters in brain microdialysis samples","volume":"44","author":"Zhang","year":"2007","journal-title":"J Pharm Biomed Anal"},{"issue":"1\u20133","key":"10.1016\/j.pbb.2011.02.002_bb2000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.03.054","article-title":"BZYX, a novel acetylcholinesterase inhibitor, significantly improved chemicals-induced learning and memory impairments on rodents and protected PC12 cells from apoptosis induced by hydrogen peroxide","volume":"24; 613","author":"Zhang","year":"2009","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T15:14:33Z","timestamp":1740928473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305711000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":390,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0091305711000414"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2011.02.002","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}